SG10201401278WA - Heparan Sulphate - Google Patents

Heparan Sulphate

Info

Publication number
SG10201401278WA
SG10201401278WA SG10201401278WA SG10201401278WA SG10201401278WA SG 10201401278W A SG10201401278W A SG 10201401278WA SG 10201401278W A SG10201401278W A SG 10201401278WA SG 10201401278W A SG10201401278W A SG 10201401278WA SG 10201401278W A SG10201401278W A SG 10201401278WA
Authority
SG
Singapore
Prior art keywords
heparan sulphate
heparan
sulphate
Prior art date
Application number
SG10201401278WA
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Publication of SG10201401278WA publication Critical patent/SG10201401278WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/34—Sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Dermatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG10201401278WA 2010-10-08 2011-10-07 Heparan Sulphate SG10201401278WA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39111610P 2010-10-08 2010-10-08

Publications (1)

Publication Number Publication Date
SG10201401278WA true SG10201401278WA (en) 2014-05-29

Family

ID=45925311

Family Applications (2)

Application Number Title Priority Date Filing Date
SG2011073699A SG180097A1 (en) 2010-10-08 2011-10-07 Heparan sulphate
SG10201401278WA SG10201401278WA (en) 2010-10-08 2011-10-07 Heparan Sulphate

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG2011073699A SG180097A1 (en) 2010-10-08 2011-10-07 Heparan sulphate

Country Status (2)

Country Link
US (1) US9044496B2 (en)
SG (2) SG180097A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9664671B2 (en) 2012-07-24 2017-05-30 Nissan Chemical Industries, Ltd. Culture medium composition and method of culturing cell or tissue using thereof
US10017805B2 (en) 2012-08-23 2018-07-10 Nissan Chemical Industries, Ltd. Enhancing ingredients for protein production from various cells
US20160060601A1 (en) * 2013-04-17 2016-03-03 Nissan Chemical Industries, Ltd. Medium composition and method for producing red blood cells using same

Also Published As

Publication number Publication date
SG180097A1 (en) 2012-05-30
US20120087899A1 (en) 2012-04-12
US9044496B2 (en) 2015-06-02

Similar Documents

Publication Publication Date Title
HRP20181800T1 (en) Well
DK3342786T3 (en) Anti-dll3-antistof
AP3107A (en) 5-Alkynyl-pyrimidines
EP2566479A4 (en) Azaindazoles
EP2640189A4 (en) 3-deutero-pomalidomide
AP2012006640A0 (en) New aminopyrazoloquinazolines
GB201012176D0 (en) Well
ZA201207252B (en) Can manufacture
DK3466977T3 (en) Anti-vla-4-antistoffer
PL2568946T3 (en) Shape
ZA201208514B (en) Can manufacture
GB2485334B (en) Structure
EP2641891A4 (en) Pkc- activator
ZA201205621B (en) Can manufacture
GB2473907B (en) Flood-proof doors
GB2476879B (en) Swimmer-propulsion units
GB2477296B (en) Wall section
EP2591985A4 (en) Panel-joining structure
SG10201401278WA (en) Heparan Sulphate
GB201121151D0 (en) Closures
GB2483908B (en) Nacelle
EP2527561A4 (en) Skirting-board profile
AU4536P (en) TB01 Tibouchina urvilleana
AU4937P (en) FlatinsulGL Myoporum insulare
AU4931P (en) FlatwaxDarkGL Chamelaucium uncinatum